1.Al, R. H., Y. Xie, Y. Wang, and C. H. Hagedorn. 1998. Expression of recombinant hepatitis C virus non-structural protein 5B in Escherichia coli. Virus Res. 53:141-149.
2.Ali, N., and A. Siddiqui. 1997. The La antigen binds 5* noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc. Natl. Acad. Sci. USA 94:2249-2254.
3. Alter, H. J., R. H. Purcell, P. V. Holland, S. M. Feinstone, A. G. Morrow, and Y. Moritsugu. 1975. Clinical and serological analysis of transfusion-associated hepatitis. Lancet 2:838-841.
4. Alter H. J., R. H. Purcell, J. W. Shih, J. C. Melpolder, M. Houghton, Q.-L. Choo, and G. Kuo. 1989. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 321:1494-1500.
5. Asabe, S. I., Y. Tanji, S. Satoh, T. Kaneko, K. Kimura, and K. Shimotohno. 1997. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation. J. Virol. 71:790-796.
6. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1993. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67:3835-3844.
7. Bassett, S. E., D. L. Thomas, K. M. Brasky, and R. E. Lanford. 1999. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J. Virol. 73:1118-1126.
8. Behrens, S.-E., L. Tomei, and R. De Francesco. 1996. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO 15:12-22.
9. Blight, K., R. Trowbridge, R. Rouland, and E. Growan. 1992. Detection of hepatitis C virus RNA by in situ hybridization. Liver. 12:286-289.
10. Blight, K. J., and C. M. Rice. 1997. Secondary structure determination of the conserved 98-base sequence at the 3'' terminus of hepatitis C virus genome RNA. J. Virol. 71:7345-7352.
11. Blumberg, B. S., H. J. Alter, and S. Visnich. 1965. "A new" antigen in leukemia sera. JAMA 191:541-546.
12. Blumenthal, T., and G. C. Carmichael. 1979. RNA replication: function and structure of Qbeta-replicase. Annu. Rev. Biochem. 48:525-548.
13. Borowski, P., K. Oehlmann, M. Heiland, and R. Laufs. 1997. Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase. J. Virol. 71:2838-2843.
14. Borowski, P., J. S. zur Wiesch, K. Resch, H. Feucht, R. Laufs, and H. Schmitz. 1999. Protein kinase C recognizes the protein kinase A-binding motif of nonstructural protein 3 of hepatitis C virus. J. Biol. Chem. 274:30722-30728.
15. Chambers, T. J., C. S. Hahn, R. Galler, and C. M. Rice. 1990. Flavivirus genome organization, expression, and replication. Annu. Rev. of Micro. 44:649-688.
16. Chang, M.-F., S. C. Baker, L. H. Soe, T. Kamahora, J. G. Keck, S. Makino, S. Govindarajan, and M. M. C. Lai. 1988. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. 62:2403-2410.
17. Chang, M.-F., C.-Y. Sun, C.-J. Chen, and S. C. Chang. 1993. Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J. Virol. 67:2529-2536.
18. Chang, S. C., J.-H. Yen, H.-Y. Kang, M.-H. Jang, and M.- F. Chang. 1994. Nuclear localization signals in the core protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 205:284-1290.
19. Chang, M.-H., C. J. Chen, M.-S. Lai, H.-M. Hsu, T.-C. Wu, M.-S. Kong, D.-C. Liang, W.-Y. Shau, and D.-S. Chen. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336:1855-1859.
20. Chen. C. J., M. D. Kuo, L. J. Chien, S. L. Hsu, Y. M. Wang, and J. H. Lin. 1997. RNA-protein interactions: involvement of NS3, NS5, and 3'' noncoding regions of Japanese encephalitis virus genomic RNA. J. Virol. 71:3466-3473.
21. Chen, D. S., G, Kuo, J. L. Sung, M. Y. Lai, J. C. Sheu, P. J. Chen, H. M. Hsu, M. H. Chang, C. J. Chen, L. C. Hahn, Q. L. Choo, T. H. Wang, and M. Houghton. 1990. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J. Infect. Dis. 162:817-822.
22. Chen, P.-J., M. Lin, K.-F. Tai, P.-C. Liu, C.-J. Lin, and D.-S. Chen. 1992. The Taiwanese hepatitis C virus genome: sequence determination and mapping the 5'' terminus of viral genomic and antigenomic RNA. Virology 88:102-113.
23. Cheng, J.-C., M.-F. Chang, and S. C. Chang. 1999. Specific interaction between the hepatitis C virus NS5B RNA polymerase and the 3* end of the viral RNA. J. Virol. 73:7044-7049.
24. Cho, H.-S., N.-C. Ha, L.-W. Kang, K. M. Chung, S. H. Back, S. K. Jang, and B.-H. Oh. 1998. Crystal structure of RNA helicase from genotype 1b hepatitis C virus: a feasible mechanism of unwinding duplex RNA. J. Biol. Chem. 273:15045-15052.
25. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
26. Choo, Q.-L., K. H. Richman, J. H. Han, K. Berger, C. Lee, C. Dong, C. Gallegos, D. Coit, A. Medina-Selby, P. J. Barr, A. J. Weiner, D. W. Bradley, G. Kuo, and M. Houghton. 1991. Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. USA 88:2451-2455.
27. Chung, R. T., A. Monto, J. L. Dienstag, L. M. Kaplan. 1999. Mutations in the NS5A region do not predict interferon-responsiveness in American patients infected with genotype 1b hepatitis C virus. J. Med. Virol. 58:353-358.
28. Chung, R. T., and L. M. Kaplan. 1999. Heterogeneous nuclear ribonucleoprotien I (hnRNP-I/PTB) selectively binds the conserved 3* terminus of hepatitis C viral RNA. Biochem. Biophys. Res. Commun. 254:351-362.
29. Collett, M. S., R. Larson, S. K. Belzer, and E. Retzel.1988. Proteins encoded by bovine viral diarrhea virus: the genomic organization of a pestivirus. Virology. 165: 200- 208.
30. Cui, T., and A. G. Porter. 1995. Localization of binding site for encephalomyocarditis virus RNA polymerase in the 3''-noncoding region of the viral RNA. Nucleic Acids Res. 23:377-382.
31. Cui, T., S. Sankar, and A. G. Porter. 1993. Binding of encephalomyocarditis virus RNA polymerase to the 3''-noncoding region of the viral RNA is specific and requires the 3''-poly(A) tail. J. Biol. Chem. 268:26093-26098.
32. Dane D.S. C.H. Cameron, M. Briggs. 1970. Virus like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1:695-698.
33. De Francesco, R., S.-E. Behrens, L. Tomei, S. Altamura, and J. Jiricny. 1996. RNA-dependent RNA polymerase of hepatitis C virus. Methods Enzymol. 275:58-67.
34. Deiman, B. A. L. M., A. K. Koenen, P. W. G. Verlaan, and C. W. A. Pleij. 1998. Minimal template requirements for initiation of minus-strand synthesis in vitro by the RNA-dependent RNA polymerase of turnip yellow mosaic virus. J. Virol. 72:3965-3972.
35. Di Bisceglie, A. M. 1995. Hepatitis C and hepatocellular carcinoma. Semin. Liver Dis. 15:64-69.
36. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, N. Izumi, F. Marumo, and C. Sato. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J. Clin. Invest. 96:224-230.
37. Enomoto, N., I. Sakuma, Y. Asahina, M. Kurosaki, T. Murakami, C. Yamamoto, Y. Ogura, N. Izumi, F. Marumo, and C. Sato. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 334:77-81.
38. Errington, W., A. D. Wardell, S. McDonald, R. D. Goldin, and M. J. McGarvey. 1999. Subcellular location of NS3 in HCV-infected hepatocytes. J. Med.Virol. 59:456-462.
39. Failla, C., L. Tomei, and R. De Francesco. 1994. Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol. 68:3753-3760.
40. Fan, Z., Q. R. Yang, J. S. Twu, A. H. Sherker. 1999. Specific in vitro association between the hepatitis C viral genome and core protein. J. Med. Virol. 59:131-134.
41. Farci, P., H. J. Alter, S. Govinndarajan, D. C. Wong, R. R. Lesniewski, I. K. Mushahwar, S. M. Desai, R. H. Millwe, N. Orgata, and R. H. Purcell. 1992. Lack of protective immunity against reinfection with hepatitis C virus. Science. 258: 135-140
42. Feinstone, S. M., A. Z. Kapikian, and R. H. Purcell. 1973. Hepatitis A detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 182:1026-1028.
43. Ferrari, E., W.-M. Jacquelyn, J. W. S. Fang, B. M. Baroudy, J. Y. N. Lau, and Z. Hong. 1999. Characterization of soluble hepatitis C virus RNA-dependent RNA polymerase expressed in Escherichia coli. J. Virol. 73:1649-1654.
44. Flint, M., C. Maidens, L. D. Loomis-Price, C. Shotton, J. Dubuisson, P. Monk, A. Higginbottom, L. Shoshana, and J. A. Mackeating. 1999. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73:6235-6244.
45. Fournillier, A., E. Depla, P. Karayiannis, O. Vidalin, G. Maertens, C. Trepo, G. Inchauspe. 1999. Expression of noncovalent hepatitis C virus envelope E1-E2 complexes is not required for the induction of antibodies with neutralization properties following DNA immunization. J. Virol. 73:7497-7504.
46. Francki, R. I. B., C. M. Fauquet, D. L. Knudson, and F. Brown. 1991. Classification and nomenclature of virus. Fifth report of the international committee on taxonomy of viruses. Arch. Virol. 2:223-233.
47. Fukushi, S., C. Kurihara, N. Ishiyama, F. B. Hoshino, A. Oya, and K. Katayama. 1997. The sequence element of the internal ribosome entry site and a 25-kilodalton cellular protein contribute to efficient internal initiation of translation of hepatitis C virus RNA. J. Virol. 71:1662-1666.
48. Gale, M. Jr, C. M. Blakely, B. Kwieciszewski, S. L. Tan, M. Dossett, N. M. Tang, M. J. Korth, S. J. Polyak, D. R. Gretch, and M. G. Katze. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol. Cell Biol. 18:5208-5218
49. Gale, M. Jr, B. Kwieciszewski, M. Dossett, H. Nakao, and M. G. Katze. 1999. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J. Virol. 73:6503-6516.
50. Gallinari, P., D. Brennan, C. Nardi, M. Brunetti, L. Tomei, C. Steinkuhler, and R. De Francesco. 1998. Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J. Virol. 72:6758-6769.
51. Gallinari, P., C. Paolini, D. Brennan, C. Nardi, C. Steinkuhler, R. De Francesco. 1999. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A. Biochemistry. 38:5620-5632.
52. Ghosh, A. K., R. Steele, K. Meyer, R. Ray, and R. B. Ray. 1999. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J. Gen. Virol. 80:1179-1183.
53. Gontarek, R. R., L. L. Gutshall, K. M. Herold, J. Tsai, G. M. Sathe, J. Mao, C. Prescott, and A. M. Del Vecchio. 1999. hnRNP C and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region within the 3*NTR of the HCV RNA genome. Nucleic Acids Res. 15:1457-1463.
54. Gorbalenya, A. E., and E. V. Koonin. 1993. Helicases: amino acid sequence comparisons and structure-function relationships. Curr. Opin. Struct. Biol. 3:419-429.
55. Gorbalenya, A. E., E. V. Koonin, A. P. Donchenko, and V. M. Blinov. 1989. Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes. Nucleic Acids Res. 17:4713-4730.
56. Grakoui, A., D. W. McCourt, C. Mychowski, S. M. Feinstone, and C. M. Rice. 1993a. Characterization of hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832-2843.
57. Grakoui, A., C. Wychowski, C. Lin, S. M. Feinstone, and C. M. Rice. 1993b. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1385-1395.
58. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993c. A second hepatitis C virus-encoded proteinase. Proc. Natl. Acad. Sci. USA 90:10583-10587.
59. Han, J. H., and M. Houghton. 1992. Group specific sequences and conserved secondary structures at the 3'' end of HCV genome and its implication for viral replication. Nucleic Acids Res. 20:3520.
60. Han, J. H., V. Shyamala, K. H. Richman. M. J. Brauer, B. Irvine, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q.-L. Choo, and M. Houghton. 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5* untranslated region and poly(A) tails at the 3* end. Proc. Natl. Acad. Sci. USA 88:1711-1715.
61. Heilek, G. M., and M. G. Peterson. 1997. A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J. Virol. 71:6264-6266.
62. Hijikata M., N. Kato, Y. Ootsuyama, M. Nakagawa, and K. Shimotohno. 1991. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA 88:5547-5551.
63. Hijikata, M., H. Mizushima, Y. Tanji, Y. Komoda, Y. Hirowatari, T. Akagi, N. Kato, K. Kimuran, and K. Shimotohno. 1993a. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc. Natl. Acad. Sci. USA 90:10773-10777.
64. Hijikata, M., H. Mizushima, T. Akagi, S. Mori, N. Kakiuchi, N. Kato, T. Tanaka, K. Kimura, and K. Shimotohno. 1993b. Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J. Virol. 67:4665-4675.
65. Hirota, M., S. Satoh, S. Asabe, M. Kohara, K. Tsukiyama-Kohara, N. Kato, M. Hijikata, K. Shimotohno. 1999. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. Virology 257:130-137.
66. Honda, M., E. A. Brown, S. M. Lemon. 1996a. Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2:955-968.
67. Honda, M., L.-H. Ping, R. C. Rijnbrand, E. Amphlett, B. Clarke, D. Rowlands, and S. M. Lemon. 1996b. Structural requirements for initiation of translation by internal ribosome entry within genome-length hepatitis C virus RNA. Virology 222:31-42.
68. Honda, M., M. R. Beard, L. H. Ping, and S. M. Lemon. 1999.A phylogenetically conserved stem-loop structure at the 5* border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J. Virol. 73:1165-1174.
69. Horiike, N., K. Michitaka, T. Masumoto,I. Okura, S. M. Akbar, and M. Onji. 1999. Relationnship between the effect of interferon therapy and the change of hepatitis C virus non-strucural 5B gene. J. Gastroenterol. Hepatol. 14:345-351.
70. Houghton, M. A. J. Weiner, J. H. Han, G. Kou, and Q.-L. Choo.1991. Molecular biology of the hepatitis C virus: implication for diagnosis, development and control of viral disease. Hepatology 14:381-388.
71. Howe, A. Y., R. Chase, S. S. Taremi, C. Risano, B. Beyer, B. Malcolm, and T. Y. Lau. 1999. A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity. Protein Sci. 8:1332-1341.
72. Hwang, L. H., C. L. Hsieh, A. Yen, Y. L. Chung, and D. S. Chen. 1998. Involvenment of the 5* proximal coding sequences of hepatitis C virus with internal initiation of viral translation. Biochem. Biophy. Res. Commun. 252:455-460.
73. Hwang, S. B., K.-J. Park, Y.-S. Kim, Y. C. Sung, and M. M. C. Lai. 1997. Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology 227:439-446.
74. Ide, Y, L. Zhang, M. Chen, G. Inchauspe, C. Bahl, Y. Sasaguri, and R. Padmanabhan. 1996. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182:203-211.
75. Ishido, S., Fujita T., and Hotta. H. 1998. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244:35-40.
76. Ishii, K., Y., Tanaka, C. C. Yap, H. Aizaki, Y. Matsuura, and T. Miyamura. 1999. Expression of hepatitis C virus NS5B protein:characterization of its RNA polymerase activity and RNA binding. Hepatology. 29:1227-1235.
77. Ito, T., and M. M. C. Lai. 1997. Determination of the secondary structure of and cellular protein binding to the 3''-untranslated region of the hepatitis C virus RNA genome. J. Virol. 71:8698-8706.
78. Jacobson, S. J., D. A. M. Konings, and P. Sarnow. 1993. Biochemical and genetic evidence for a pseudoknot structure at the 3* terminus of the poliovirus RNA genome and its role in viral RNA amplification. J. Virol. 67:2961-2971.
79. Kaito, M., S. Watanabe, K. Tsukiyama-Kohara, K. Yamaguchi, Y. Kobayashi, M. Konishi, M. Yokoi, S. Ishida, S. Suzuki, and M. Kohara. 1994. Hepatitis C virus particle detected by immunoelectron microscopic study. J. Gen. Vipol.75:1755-1760.
80. Kamer, G., and P. Argos. 1984. Primary structural comparison of RNA-dependent polymerase from plant, animal and bacterial viruses. Nucleic Acids Res. 12:7269-7282.
81. Kaneko, T., Y. Tanji, S. Satoh, M. Hijikata, S. Asabe, K. Kimura, and K. Shimotohno. 1994. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. Biochem. Biophys. Res. Commun. 205:320-326.
82. Kao, J. H., P. J. Chen, M. Y. Lai, P. M. Yang, J. C. Sheu, T. H. Wang, and D. S. Chen. 1994a. Mixed infection of hepatitis C virus a s a factor in acute exacerbation of chronic type C hepatitis. J. Infect. Dis. 170:1128-1133.
83. Kao, J. H., S. L.Tsai, P. M. Yang, J. C. Sheu, M. Y. Lai, H. C. Hsu, J. L. Sung, T. H. Wang, and D. S. Chen. 1994b. A clinic-pathologic study of chronic non-A, non-B (type C) hepatitis C in Taiwan: comparison between posttransfusion and sporadic patients. J. Hepatol. 21:244-249.
84. Kao, J. H., P. J, Chen, M. Y. Lai, P. M. Yang, J.C. Sheu, T. H. Wang, and D. S. Chen. 1995b. Genotypes of hepatitis C virus in Taiwan and the progression of liver disease. J. Clinical Gastroenterology 21:231-237.
85. Kao, J. H., P. M. Yang, M. Y. Lai, P. J. Chen, T. H. Wang, and D. S. Chen. 1995c. Evaluation of third-generation hepatitis C antibody assay in chronic hepatitis C and chronic non-B, non-C hepatitis. Viral. Immunol. 8:135-139.
86. Kao, J. H., P. J. Chen, M. Y. Lai, P. M. Yang, T. H. Wang, and D. S. Chen. 1996a. Superinfection of homotypic virus in hepatitis C virus carriers: studies on
patient with posttransfusion hepatitis. J. Med. Virol. 50:303-308.
87. Kao, J. H., M. Y. Lai, P. J. Chen, L. H. Hwang, and D. S. Chen. 1996b. Serum hepatitis C virus titers in the progression of type C chronic liver disease: with special emphasis on patients with type 1b infection. J. Clin. Gastroenterol. 23:280-283.
88. Kapoor M., Zhang L., Raamachandea M., Kusukawa J., Ebner K. E., and Padmanabhan R. (1995) Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J. Biol. Chem. 11:19100-19106.
89. Kato N., M. Hijikata, Y. Ootsuyama, M. Nakagawa, S. Ohkohi, T. Sugimura, and K. Shimotohno. 1990. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. USA 87:9524-9528.
90. Kato, N., K. H. Lan, S. K. Ono-Nita, Y. Shiratori, and M. Omata. 1997. Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. J. Virol. 71:8856-8859.
91. Kim, D. W., Y. Gwack, J. H. Han, and J. Choe. 1995. C-terminal domain of the hepatitis C virus NS3 protein contains an RNA helicase activity. Biochem. Biophys. Res. Commun. 215:160-166.
92. Kim, D. W., J. Kim, Y. Gwack, J. H. Han, and J. Choe. 1997. Mutational analysis of the hepatitis C virus RNA helicase. J. Virol. 71:9400-9409.
93. Kim, J. L., K. A. Morgenstern, J. P. Griffith, M. D. Dwyer, J. A. Thomson, M. A. Murcko, C. Lin, and P. R. Caron. 1998. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6:89-100.
94. Koch, J. O., and R. Bartenschlager. 1999. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural protein NS3, NS4A, and NS4B. J. Virol. 73:7138-7146.
95. Kolykhalov, A. A., S. M. Feinstone, and C. M. Rice. 1996. Identification of a highly conserved sequence element at the 3'' terminus of hepatitis C virus genome RNA. J. Virol. 70:3363-3371.
96. Kuo, G., Q.-L. Choo, H. J. Alter, G. L. Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, J. L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier, F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Shuster, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
97. Lai, M.-Y., J. H. Kao, P. M. Yang, J. T. Wang, P. J. Chen, K. W. Chan, J. S. Chu, and D. S. Chen.1996. Long-term efficacy of Ribavirin plus interferon alfa in the treatment of chronic hepatitis C. Gastroenterology.111:1-6.
98. Large, M. K., D. J. Kittlesen, and Y. S. Hahn. 1999. Suppression of host immune response by the core protein of hepatitis C virus: positive implication for hepatitis C virus persistence. J. immunol. 162:931-938.
99. Lesburg, C. A., M. B. Cable, E. Ferrari, Z. Hong, A. F. Mannarino, and P. C. Weber. 1999. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Biol. 6:937-943.
100. Levin, M. K. and S. S. Patel. 1999. The helicase from hepatitis C virus is active as an oligomer. J. Biol. Chem. 274:31839-31846.
101. Lin, C., B. D. Lindenbach, B. M. Pragai, D. W. McCourt, and C. M. Rice. 1994. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68:5063-5073.
102. Lin, C., J.A. Thomson, and C.M. Rice. 1995. A central region in the hepatitis C virus NS4a protein allows formation of an active NS3-NS4a serine proteinase complex in vivo and in vitro. J. Virol. 69:4373-4380.
103. Lin, C., and J. L. Kim. 1999. Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J. Virol. 73:8798-8807.
104. Lin, Y.-J., C.-L. Liao, and M. M. C. Lai. 1994. Identification of the cis-acting signal for minus strand RNA synthesis of a murine coronavirus: implication for the role of minus-strand RNA in RNA replication and transcription. 68:8131-8140.
105. Linnen, J., J. Wages, Jr., Z. Y. Zhang-Keck, et al. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271:505-508.
106. Liou T.C. T. T. Chang, K. C. Young, X. Z. Lin, C. Y. Lin., and H. L. Wu. 1992. Detection of HCV RNA in Urine, Seminal fluid and ascites. J.Med. Virol. 37:197-202.
107. Liu, Q., R. A. Bhat, A. M. Prince, and P. Zhang. 1999. The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation. Biochem. Biophys. Res. Commun. 254:572-577.
108. Lo, S.-Y., M. Sely, and J.-H. Ou 1996. Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. 70:5177-5182.
109. Lohmann, V., F. Korner, U. Herian, and R. Bartenschlager. 1997. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71:8416-8428.
110. Lohmann, V., A. Roos, F. Korner, JO Koch, and R. Bartenschlager. 1998. Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Virology 249:108-118.
111. Lohmann, V., H. Overton, and R. Bartenschlager. 1999. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. J. Biol Chem. 274:10807-10815.
112. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. Replication of subgenomic hepatitis C virus RNAs in a Hepatoma cell line. Science. 285:110-113.
113. Lu W. S.Y.. Lo, M. Chen, K. J. Wu, Y. K. Fung, and J.H. Ou. 1999. Activation of p53 tumor suppressor by hepatitis C virus core protein. Virology. 264:134-141.
114. Matsumoto, M., T. Y. Hsieh, N. Zhu, T. VanArsdale, S. B. Hwang, K. S. Jeng, A. E. Gorbalenya, S. Y. Lo, J. H. Ou, C. F. Ware, and M. M. C. Lai. 1997. Hepatitis C virus core protein interact with the cytoplasmic tail of lymphotoxin receptor. J. Virol. 71:1301-1309.
115. Meunier, J. C., A. Fournillier, A. Choukhi, A. Cahour, L. Cocquerel, J. Dubuisson, and C. Wychowski. 1999. Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of glycans on the formation of the HCV glycoprotein. J. Gen Virol. 80:887-896.
116. Min, K. H., Y. C. Sung, S. Y. Choi, B. Y. Ahn. 1999. Functional interaction between conserved motifs of the hepatitis C virus RNA helicase protein NS3. Virus Genes. 19:33-43.
117. Mizushima, H., M. Hijikata, Y. Tanji, K. Kimura, and K. Shimotohno. 1994. Analysis of N-terminal processing of hepatitis C virus nonstructural protein 2. J. Virol. 68:2731-2734.
118. Morgenstern, K. A., J. A. Landro, K. Hsiao, C. Lin, Y. Gu, M. S. Su, and J. A. Thomson. 1997. Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of a hepatitis C virus NS3-NS4A complex isolated from transfected COS cells. J. Virol. 71:3767-3775.
119. Muramatsu, S., S. Ishido, T. Fujita, M. Itoh, H. Hotta. 1997. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J. Virol. 71: 4954-4961.
120. Mutsunori, S., A. Toshitaka, C. David, Pendleton, et. al 1992. Induction of cytotoxic T cell to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein. 66:4098-4106.
121. Nasoff, M.S., S. L. Zebedee,G. Inchauspe, and A. M. Prince.1991. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus Proc. Natl. Acad. Sci. USA 88:5462-5466.
122. Neddermann, P., A. Clementi, and R. De Francesco. 1999. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J. Virol. 73:9984-9991.
123. Ni, Y. H., H. H. Lin, P. J. Chen, H. Y. Hsu, D. S. Chen and M. H. Chang. 1994. Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J. Hepatol. 20:641-645.
124. Oberste, M. S., and J. B. Flanegan. 1988. Measurement of poliovirus RNA polymerase binding to poliovirion and nonviral RNAs using a filter-binding assay. Nucleic Acids Res. 16 :10339-10352.
125. Oh, J. W., T. Ito, and M. M. Lai. 1999. A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J. Virol. 73:7694-7702.
126. Pause, A., N. Methot, and N. Sonenberg. 1993. The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor 4A is required for RNA binding and ATP hydrolysis. Mol. Cell. Biol. 13:6789-6798.
127. Pawlotsky, J. M. 1998 Hepatitis C virus infection: viral/host interaction. J. Virol. Hepat. 1:3-8.
128. Pawlotsky, J.M., and G. Germanidis. 1999. The non-structural 5A protein of hepatitis C virus. J. Viral. Hepat. 6:343-356.
129. Petrik, J., H., Parker, and G. J. Alexander. 1999. Human hepatic glyceraldehydes- 3-phosphate dehydrogenase binds to the poly(U) tract of the 3* non-coding region of hepatitis C virus genomic RNA. J. Gen. Virol. 80:3109-3113.
130. Pileri, P.,Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938-941.
131. Poch, O., I. Sauvaget, M. Delarue, and N. Tordo. 1989. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 8:3867-3874.
132. Polyak, S. J., D. M. Paschal, S. McArdle, M. J. Gale, Jr, D. Moradpour, and D. R. Gretch. 1999. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication. Hepatology 29:1262-1271.
133. Porter, D. J. T. 1998. A kinetic analysis of the oligonucleotide-modulated ATPase activity of the helicase domain of the NS3 protein from hepatitis C virus: the first cycle of interaction of ATP with the enzyme is unique. J. Biol. Chem. 273:14247-14253.
134. Preugschat, F., D. R. Averett, B. E. Clarke, and D. J. T. Porter. 1996. A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J. Biol. Chem. 271:24449-24457.
135. Ray, R.B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37 :209-220.
136. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray.1996. A role in the regulation of HCV-infected growth and in the transformation to tumorogenic phenotype. J. Virol. 70:4438-4443.
137. Reynolds, J. E., A. Kaminski, H. J. Kettinen, K. Grace, B. E. Clarke, A. R. Carroll, D. J. Rowlands, and R. J. Jackson. 1995. Unique features of internal initiation of hepatitis C virus RNA tr
138. Rozen, F., J. Pelletier, H. Trachsel, and N. Sonenberg. 1989. A lysine substitution in the ATP-binding site of eukaryotic initiation factor 4A abrogates nucleotide-binding activity. Mol. Cell. Biol. 9:4061-4063.
139. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, T. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Y. Ohta, Q.-L., Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl. Sci. Acad. USA 87:6547-6549.
140. Sakamuro, D., T. Furukawa, and T. Takegami. 1995. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol. 69: 3893-3896.
141. Sansonno,D.E.,and F. Dammacco. 1989. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease. Lancet 2:798-799.
142. Santolini, E., G. Migliaccio, and N. La Monica.1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68:3631-3641.
143. Schmid, S. R., and P. Linder. 1992. D-E-A-D protein family of putative RNA helicases. Mol. Microbiol. 6:283-292.
144. Selby, M. J., Q.-L. Choo, K. Berger, G. Kou, E. Glazer, M. Eckart, C. Lee, D. Chien, C. Kuo, and M. Houghton. 1993. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J. Gen. Virol. 74,1103-1113.
145. Shi, P.-Y., M. A. Brinton, J. M. Veal, Y. Y. Zhong, and W. D. Wilson. 1996. Evidence for the existence of a pseudoknot structure at the 3'' terminus of the flavivirus genomic RNA. Biochemistry 35:4222-4230.
146. Shiba, J., H. Ohba, Y. Matsuura, Y. Watanaba, T. Katayama, S. Kikuchi, I. Saito, and T. Miyamura.1991. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc. Natl. Acad. Sci. USA 88:4641-4645.
147. Shoji, I., T. Suzuki, M. Sato, H., Aizaki, T. Chiba, Y. Matsuura, and T. Miyamura. 1999. Internal processing of hepatitis C virus NS3 protein. Virology. 254:315-324.
148. Simmonds, P., E. C. Holmes, T. A. Cha, S. W. Chan. F. McOmish, B. Irvie, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotype and a series of subtypes by phylogenetic analysis of the NS5 region. J. Gen Virol. 74:2391-2399.
149. Singh R. N. and T. W. Dreher. 1997. Turnip yellow mosaic virus RNA-dependent RNA polymerase: initiation of minus strand synthesis in vitro. Virology 233:430-439.
150. Song, C., and A. E. Simon. 1995. Requirement of a 3''-terminal stem-loop in in vitro transcription by an RNA-dependent RNA polymerase. J. Mol. Biol. 254:6-14.
151. Suzich, J. A., J. K. Tamura, F. Palmer-Hill, P. Warrener, A. Grakoui, C. M. Rice, S. M. Feinstone, and M. S. Collett. 1993. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J. Virol. 67:6152-6158.
152. Suzuki, R., T. Suzuki, K. Ishii, Y. Matsuura, and T. Miyamura. 1999. Processing and functions of hepatitis C virus proteins. Intervirology 42:145-152.
153. Tai, C.-L., W.-K. Chi, D.-S. Chen, and L.-H. Hwang. 1996. The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J. Virol. 70:8477-8484.
154. Takahashi, K., S. Kishimoto, H. Yoshizawa, H. Okamoto, A. Yoshizawa, and S. Mishiro. 1992. p26 protein and 33 nm particle associated with nucleocapsid of hepatitis C virus recovered from the circulation of infected hosts. Virology 191:431-434.
155. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65:1105-1113.
156. Tanaka, T., N. Kato, M.-J. Cho, and K. Shimotohno. 1995. A novel sequence found at the 3* terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. 215:744-749.
157. Tanaka, T., N. Kato, M.-J. Cho, K. Sugiyama, and K. Shimotohno. 1996. Structure of the 3'' terminus of the hepatitis C virus genome. J. Virol. 70:3307-3312.
158. Tang, S., A. J. Collier, and R. M. Elliott. 1999. Alternation to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5* untranslated region (5*UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5*UTR sequence. J. Virol. 73:2359-2364.
159. Tanimoto, A., Y. Ide, N. Arima, Y. Sasaguri, R. Padmanabhan. 1997. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochem. Biophys. Res. Commun. 236:360-364.
160. Tanji, Y., T. Kaneko, S. Satoh, and K. Shimotohno. 1995. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol.69: 3980-3986.
161. Taylor, D. R., S. T. Shi, P. R. Romano, G. N. Barber, and M. M. C. Lai. 1999. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science. 285:107-110.
162. Tomei, L., C. Failla, E. Santolini, R. De Francesco, and N. La Monica. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:4017-4026.
163. Tsuchihara K., T. Tanaka, M. Hijikata, S. Kuge, H. Toyoda, A. Nomoto, N. Yamamoto, and K. Shimotohno. 1997. Specific interaction of polypyrimidine tract-binding protein with the extreme 3''-terminal structure of the hepatitis C virus genome, the 3''X. J. Virol. 71:6720-6726.
164. Tsukiyama-Kohara K., N. Iizuka, M. Kohara, and A. Nomoto. 1992. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66:1476-1483.
165. Tu., C, T. H. Tzeng, and J. A., Bruenn. 1992. Ribosomal movement impeded at a pseudoknot required for frame shifting. Proc. Natl. Acad. Sci. USA 89:8636-8640.
166. Tu, H., L. Gao, S. T. Shi, D. R. Taylor, T. Yang, A. K. Mircheff, Y. Wen, A. E. Gorbalenya, S. B. Hwang and M. M. Lai. 1999. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 263:30-41.
167. Walker, J. E., M. Saraste, M. J. Runswick, and N. J. Gay. 1982. Distantly related sequences in the *- and *-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1:945-951.
168. Wang, C., P. Sarnow, and A. Siddiqui. 1993. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome binding mechanism. J. Virol. 67:3338-3344.
169. Warrener, P., J. K. Tamura, and M. S. Collett. 1993. RNA stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria. J. Virol. 67:989-996.
170. Weiner, a. J. M. J. Brauer, J. Rosenblatt, K. H. Richman, J. Tung, K. Cawford, F. Bonino, G. Saracco, Q. L. Choo, M. Houghton, and J. H. Han. 1991. Variable and hypervariable domains are found in the region of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology. 180:842-848.
171. Westaway E. G. 1987. Flavivirus replication strategy. Adv. Virus Res. 33:45-90.
172. Yamada, N., K. Tanihara, A. Takada, T. Yorihuzi, M. Tsutsumi, H. Shimomura, T. Tsuji, and T. Date. 1996. Genetic organization and diversity of the 3'' noncoding region of the hepatitis C virus genome. Virology 223:255-261.
173. Yamashita, T., S. Kaneko, Y. Shirota, W. Qin, T. Nomura, K. Kobayashi, and S. Murakami. 1998. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J. Biol. Chem. 273:15479-15486.
174. Yao, N., T. Hesson, M. Cable, Z. Hong, A. D. Kwong, H. V. Le, and P. C. Weber. 1997. Structure of the hepatitis C virus RNA helicase domain. Nat. Struct. Biol. 4:463-467.
175. Yen, J.-H., S. C. Chang, C.-R. Hu, S.-C. Chu, S.-S. Lin, Y.-S. Hsieh, and M.-F. Chang. 1995. Cellular proteins specifically bind to the 5*-noncoding region of hepatitis C virus RNA. Virology 208:723-732.
176. You, L. R., C. M. Chen, and Y. H. W. Lee. 1999. Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J. Virol. 73:1672-1681.
177. Yu., W., and J. L. Leibowitz. 1995. A conserved motif at the 3* end of mouse hepatitis virus genomic RNA required for host protein binding and viral RNA replication. Virology. 214: 128-138.
178. Yuan, Z-H., U. Kumar, H. C. Thomas, Y-M. Wen, and J. Monjardino. 1997.
Expression, purification, and partial characterization of HCV RNA polymerase. Biochem. Biophys. Res. Commun. 232:231-235.
179. Zignego, A. L., D. Macchia, M. Monti, V. Thiers, M. Mazzetti, M. Foschi, E. Maggi, S. Romagnani, P. Gentilini, and C. Brechot. 1992. Infection of peripheral mononuclear blood cells by hepatitis C virus. J. Hepatol. 15:382-386.
180. 陳知信. 1993. D 型肝炎抗原在大腸桿菌中的表現. 碩士論文
181. 高詮宏. 1994. C 型肝炎病毒 NS3 基因表現與其功能研究. 碩士論文
182. 邱瓊慧. 1996. C 型肝炎病毒 NS3 結合ATP 及 RNA 之功能區分析. 碩士論文183. 許曉薇. 1999. C 型肝炎病毒核心蛋白質調控 p21(WAF1/CIP1)基因之分子機制. 碩士論文184. 張靜怡. 1999. C 型肝炎病毒非轉譯區與細胞因子之交互作用. 碩士論文